Abiopharma

News list

Byers David Raynor 🟡 adjusted position in 9.8K shares of Ardent Health, Inc. (ARDT) at $8.67 Transaction Date: Mar 31, 2026 | Filing ID: 023206

Full text

News bot April 2, 2026, 8:26 p.m.
🔍 Byers David Raynor (Executive)

Company: Ardent Health, Inc. (ARDT)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 11,538
- Total shares sold: 1,743
Detailed Transactions and Holdings:
- Sold 819 shares of Common Stock at $8.56 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 119,831.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Sold 924 shares of Common Stock at $8.67 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 118,907.00 | transaction_form_type: 4 | Footnotes: F1, F3
- Acquired 11,538 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 130,445.00 | transaction_form_type: 4 | Footnotes: F4
Footnotes:
- F1: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
- F2: Represents the closing price of the common stock of the Issuer on March 31, 2026.
- F3: Represents the closing price of the common stock of the Issuer on April 1, 2026.
- F4: Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date